QIN Suping. Research on levels of C reactive protein and homocysteine in elderly patients with dementia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 56-58. DOI: 10.7619/jcmp.202011015
Citation: QIN Suping. Research on levels of C reactive protein and homocysteine in elderly patients with dementia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 56-58. DOI: 10.7619/jcmp.202011015

Research on levels of C reactive protein and homocysteine in elderly patients with dementia

More Information
  • Received Date: March 10, 2020
  • Available Online: August 27, 2020
  • Objective To explore the levels of serum C reactive protein(CRP)and homocysteine(Hcy)in elderly patients with dementia and their correlations with severity of dementia. Methods The serum CRP and Hcy levels were compared among AD group [45 patients with Alzheimer's disease(AD)], VD group [35 patients with vascular dementia(VD)] and control group(31 healthy controls). According to the severity of dementia, the patients were divided into mild dementia group, moderate dementia group and severe dementia group.The levels of CRP and Hcy in different groups were compared. Results The levels of CRP and Hcy in the AD group and the VD group were significantly higher than those in the control group(P<0.01), and the levels of CRP and Hcy in the VD group were significantly higher than those in the AD group(P<0.01). Correlation analysis showed that there were no significant correlations between CRP level and score of Mini-mental State Examination(MMSE)Scale, age and severity of dementia in the AD group(P>0.05). There was a significant negative correlation between serum CRP level and MMSE score in the VD group(r=-0.399, P=0.018), a significant positive correlation between CRP level and age(r= 0.426, P=0.011), but no significant correlation between CRP level and severity of dementia(P>0.05). In the AD group, the Hcy level was negatively correlated with MMSE score and severity of dementia(r=-0.732, -0.721, P=0.001, 0.001), but had no significant correlation with age(r=-0.172, P=0.258). In the VD group, the Hcy level was negatively correlated with MMSE score and severity of dementia(r=-0.402, -0.452, P=0.017, 0.006), but had no significant correlation with age(r=0.131, P=0.454). The levels of CRP and Hcy in mild dementia group(n=20), moderate dementia group(n=49)and severe - dementia group(n=11)were significantly higher than those in the control group(P<0.01), and the levels of Hcy in moderate dementia group and severe dementia group were significantly higher than that in mild dementia group(P<0.01). Conclusion In elderly patients with dementia, the detections of serum CRP and Hcy levels are helpful for the differential diagnosis of AD and VD, and may be helpful in judging the progression and prognosis of patients with dementia.
  • Vishnu V Y, Modi M, Garg V K, et al. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia-A pilot study from a tertiary center in Northern India[J]. Asian J Psychiatr, 2017, 29: 59-62.
    Cipollini V, Troili F, Giubilei F. Emerging biomarkers in vascular cognitive impairment and dementia: from pathophysiological pathways to clinical application[J]. Int J Mol Sci, 2019, 20(11): E2812-E2818.
    Birkenhäger W H, Staessen J A. Convergence of atherosclerosis and Alzheimer's disease[J]. Lancet, 2004, 363(9426): 2091-2097.
    Morgan A R, Touchard S, Leckey C, et al. Inflammatory biomarkers in Alzheimer's disease plasma[J]. Alzheimers Dement, 2019, 15(6): 776-787.
    Lehmann D J, Cortina-Borja M. Genetic influence of plasma homocysteine on Alzheimer's disease[J]. Neurobiol Aging, 2019, 76: 217-218.
    Nilsson K, Gustafson L, Hultberg B. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time[J]. Clin Biochem, 2011, 44(14/15): 1205-1208.
    Strang F, Scheichl A, Chen Y C, et al. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease[J]. Brain Pathol, 2012, 22(3): 337-346.
    Hsu P F, Pan W H, Yip B S, et al. C-reactive protein predicts incidence of dementia in an elderly Asian community cohort[J]. J Am Med Dir Assoc, 2017, 18(3): 277-288.
    Ray L, Khemka V K, Behera P, et al. Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein(a)in Alzheimer's disease and vascular dementia[J]. Aging Dis, 2013, 4(2): 57-64.
    Cervellati C, Romani A, Seripa D, et al. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia[J]. J Neurol Sci, 2014, 337(1/2): 156-161.
  • Cited by

    Periodical cited type(9)

    1. 王小雯,郭丽纳,王会敏,郭海星,石文博. 基于早期肺部CT定量检测评估中重度ARDS患者预后的价值. 中国CT和MRI杂志. 2025(03): 56-58 .
    2. 曾渊杰,宋晓龙,薛寅. 大柴胡汤加减辅助治疗急性胰腺炎(腑实热结证)的临床观察. 中国中医急症. 2025(03): 491-494 .
    3. 刘艳,帅玉婷,涂娇子,刘云,应志兰. 股动脉ECMO辅助治疗冠状动脉旁路移植术后患者预后不良的危险因素. 检验医学与临床. 2024(05): 707-711 .
    4. 张方,王娜,孟君,赵智东,崔存晓,任成波. 肺泡灌洗液病原微生物宏基因二代测序技术在难治性肺炎治疗中的应用效果. 保健医学研究与实践. 2024(04): 78-83 .
    5. 叶青,田瑞雪,侯洪颜,颜卫峰. 经鼻高流量氧疗对稳定期慢性阻塞性肺疾病合并高碳酸血症的疗效分析. 实用临床医药杂志. 2024(14): 67-71+76 . 本站查看
    6. 施静,潘溢丹. 慢性阻塞性肺疾病急性加重患者高分辨率CT肺血管参数与肺功能、病情严重程度及预后相关性分析. 陕西医学杂志. 2024(12): 1649-1653 .
    7. 胡建粤. 无创呼吸机联合氧驱动雾化吸入治疗慢性阻塞性肺病急性加重患者的疗效分析. 实用中西医结合临床. 2024(21): 46-49 .
    8. 周晓兰,杨楠,温海娟,刘秀云,罗雪娇,武彦锋,刘岩峰,李岩. 基于临床特征、实验室指标分析多重耐药鲍曼不动杆菌感染重症肺炎患者预后不良的危险因素. 中国临床医生杂志. 2024(12): 1426-1429 .
    9. 龚建,焦宪法. 重症监护室脓毒症休克患者进行山莨菪碱治疗的临床观察. 深圳中西医结合杂志. 2024(24): 120-123 .

    Other cited types(1)

Catalog

    Article views (334) PDF downloads (10) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return